Clinical Trials Browser

Phase 2 × INDUSTRY × ficlatuzumab × Clear all

NCT02318368 2020-10-22

FOCAL

Phase 2 Terminated

10 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT04100330 2020-03-31

CyFi2

Phase 2 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Acute